Imedex

CME-Course Description

Scientific Agenda

• Mycology Workshop

• Welcome/Intro Lecture

• Session II A

• Session II B

• Session III

• Session VII

• Session VIII

Satellite Symposium

• Course Description

• Scientific Agenda

Multimedia content is supported by an unrestricted educational grant from:


	FACULTY
	Elias J. Anaissie, MD University of Arkansas for Medical Sciences Little Rock, Arkansas Mark Bresnik, MD* Gilead Sciences, Inc. Foster City, California Donald Buell, MD* Astellas Pharma US, Inc. Deerfield, Illinois Leslie M. Dalton, DVM Sea World of Texas San Antonio, Texas Lorraine M. Dowdy, DO, FACP University of Miami School of Medicine Miami, Florida Annette W. Fothergill, MA, MBA University of Texas Health Science Center at San Antonio San Antonio, Texas Mahmoud Ghannoum, PhD, EMBA Case Western Reserve University School of Medicine Cleveland, Ohio John R. Graybill, MD University of Texas Health Science Center at San Antonio San Antonio, Texas Catherine J. Hardalo, MD* Schering-Plough Corporation Kenilworth, New Jersey Ivan Horak, MD* Enzon Pharmaceuticals Piscataway, New Jersey Duane R. Hospenthal, MD, PhD Brooke Army Medical Center Fort Sam Houston, Texas Ana Espinel-Ingroff, PhD Virginia Commonwealth University Richmond, Virginia Nicholas A. Kartsonis, MD* Merck & Company, Inc. Blue Bell, New Jersey Dimitrios P. Kontoyiannis, MD MD Anderson Cancer Center Houston, Texas Kieren A. Marr, MD Fred Hutchinson Cancer Research Center University of Washington Seattle, Washington Leonel Mendoza, PhD Michigan State University East Lansing, Michigan	Stephen A. Moser, PhD University of Alabama at Birmingham Birmingham, Alabama Nova Najarian, RN* Indevus Pharmaceuticals, Inc. Lexington, Massachusetts M-Hong T. Nguyen, MD University of Florida College of Medicine Gainesville, Florida Luis Ostrosky-Zeichner, MD, FACP University of Texas Health Science Center at Houston Houston, Texas Brent T. Page, PhD Agricultural Research Service US Department of Agriculture Peoria, Illinois Thomas F. Patterson, MD, FACP University of Texas Health Science Center at San Antonio San Antonio, Texas John R. Perfect, MD Duke University Medical Center Durham, North Carolina Michael A. Pfaller, MD University of Iowa College of Medicine Iowa City, Iowa Sanjay G. Revenkar, MD Dallas VA Medical Center Dallas, Texas Michael G. Rinaldi, PhD University of Texas Health Science Center at San Antonio San Antonio, Texas Jerry D. Smilack, MD Mayo Clinic Scottsdale, Arizona Deanna A. Sutton, PhD University of Texas Health Science Center at San Antonio San Antonio, Texas Robert Swanson, PhD* Pfizer Inc. New York, New York Lisa A. Tell, DVM University of California-Davis Davis, California Thomas J. Walsh, MD National Cancer Institute National Institutes of Health Bethesda, Maryland Michael J. Weickert, PhD* Nektar Therapeutics San Carlos, California John R. Wingard, MD University of Florida College of Medicine Gainesville, Florida
	*These speakers are researchers employed by pharmaceutical companies. The learner must determine if this affiliation has any influence on their presentation. Full disclosure information is provided on the faculty disclosure page.

© 2006 Imedex^®, Inc